CELESTONE

This brand name is authorized in Brazil, Mexico, Netherlands, Poland.

Active ingredients

The drug CELESTONE contains one active pharmaceutical ingredient (API):

1
UNII 9842X06Q6M - BETAMETHASONE
 

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
 
Read more about Betamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
H02AB01 Betamethasone H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 540917030026617, 540917030026717, 540917030026817, 540917030026917, 540917030027017
MX Comisión Federal para la Protección contra Riesgos Sanitarios 62193, 64063, 89908
NL Z-Index G-Standaard 12109320, 12109347
NL Z-Index G-Standaard, PRK 4359, 4367
PL Rejestru Produktów Leczniczych 100013420

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈